Increased tissue factor expression predicts development of cardiac allograft vasculopathy

Area of Science:

• Cardiology
• Immunology
• Transplantation Medicine

Background:

• Cardiac allograft vasculopathy (CAV) is a major limitation in heart transplant recipients.
• Elevated oxidized lipids and fibrin deposition are associated with increased CAV incidence.
• Tissue factor (TF) expression, influenced by oxidized lipids, was investigated in CAV patients.

Purpose of the Study:

• To investigate the association between tissue factor (TF) expression and cardiac allograft vasculopathy (CAV) in heart transplant recipients.
• To determine if TF expression can predict the development of CAV.

Main Methods:

• Developed a TF score to quantify TF expression in right heart biopsy (RHB) specimens.
• Analyzed RHB from 63 heart transplant patients undergoing routine follow-up.
• Correlated TF scores with the presence of CAV and prospectively followed patients to assess CAV development.

Main Results:

• In patients over 2 years post-transplant, a high TF score was significantly more frequent in those with CAV (75%) compared to those without (26%).
• In patients less than 2 years post-transplant, a high TF score had a 78.6% positive predictive value for developing CAV.
• A low TF score demonstrated a 100% negative predictive value for CAV development.

Conclusions:

• Early TF expression is a significant predictor of subsequent CAV development.
• Increased TF expression may link oxidized LDL and fibrin deposition in CAV pathophysiology.
• TF could serve as a prognostic marker and a therapeutic target for CAV prevention.